Holen Sie sich die Stockscreener-App
1.94
1.57%
0.03
Handel nachbörslich:
1.91
-0.03
-1.55%
Schlusskurs vom Vortag:
$1.91
Offen:
$1.93
24-Stunden-Volumen:
1.06M
Relative Volume:
0.83
Marktkapitalisierung:
$122.62M
Einnahmen:
$139.77M
Nettoeinkommen (Verlust:
$-97.62M
KGV:
-1.2278
EPS:
-1.58
Netto-Cashflow:
$-61.71M
1W Leistung:
+14.12%
1M Leistung:
+18.29%
6M Leistung:
-16.38%
1J Leistung:
-41.57%
1-Tages-Spanne:
$1.84
$2.04
1-Wochen-Bereich:
$1.7107
$2.04
52-Wochen-Spanne:
$0.9897
$5.10
Macrogenics Inc Stock (MGNX) Company Profile
Firmenname
Macrogenics Inc
Sektor
Branche
Telefon
301-251-5172
Adresse
9704 MEDICAL CENTER DRIVE, Rockville, MD
Vergleichen Sie MGNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGNX
Macrogenics Inc
|
1.94 | 109.98M | 139.77M | -97.62M | -61.71M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-07 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-01 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-07-31 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2024-07-31 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-05-10 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-05-10 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-04-26 | Eingeleitet | B. Riley Securities | Buy |
| 2024-04-09 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-03-04 | Bestätigt | BTIG Research | Buy |
| 2024-02-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-12-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-11-07 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-11-22 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-11-14 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-07-18 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2022-07-11 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2022-05-04 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-02-28 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-02-11 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-02-04 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-11-17 | Fortgesetzt | Guggenheim | Buy |
| 2021-10-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-12 | Hochstufung | Barclays | Underweight → Overweight |
| 2020-12-22 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-06-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-04 | Eingeleitet | Barclays | Underweight |
| 2019-12-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-12-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-11-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2019-11-20 | Fortgesetzt | Guggenheim | Neutral |
| 2019-05-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2019-04-12 | Eingeleitet | Guggenheim | Neutral |
| 2019-02-07 | Hochstufung | Citigroup | Sell → Buy |
| 2019-02-07 | Herabstufung | Wedbush | Outperform → Neutral |
| 2019-02-06 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2019-02-04 | Herabstufung | Citigroup | Neutral → Sell |
| 2018-12-10 | Herabstufung | Raymond James | Outperform → Underperform |
| 2018-09-10 | Fortgesetzt | BTIG Research | Buy |
| 2018-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-03-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-03-31 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Macrogenics Inc Aktie (MGNX) Neueste Nachrichten
Key metrics from MacroGenics Inc.’s quarterly dataPortfolio Return Summary & Risk Controlled Stock Pick Alerts - Newser
Measuring MacroGenics Inc.’s beta against major indicesJuly 2025 Gainers & Verified Technical Signals - Newser
Using Ichimoku Cloud for MacroGenics Inc. technicalsPortfolio Return Report & Growth-Oriented Investment Plans - Newser
Strategies to average down on MacroGenics Inc.Weekly Volume Report & Free Reliable Trade Execution Plans - Newser
Is MacroGenics Inc. forming a bottoming base2025 Market Trends & Low Drawdown Investment Ideas - Newser
Can MacroGenics Inc. stock double in the next yearJuly 2025 EndofMonth & Momentum Based Trading Ideas - khodrobank.com
Macrogenics shares rise 7.47% intraday after CEO to present at H.C. Wainwright 27th Annual Global Investment Conference. - AInvest
News impact scoring models applied to MacroGenics Inc.Weekly Trend Recap & Low Risk Entry Point Guides - Newser
How to build a dashboard for MacroGenics Inc. stockGap Up & Stepwise Entry and Exit Trade Signals - Newser
Can MacroGenics Inc. reach all time highs this yearWeekly Trade Analysis & Smart Investment Allocation Insights - khodrobank.com
Will MacroGenics Inc. benefit from macro trendsTrade Risk Assessment & Daily Volume Surge Signals - Newser
What to do if you’re stuck in MacroGenics Inc.Rate Hike & AI Driven Stock Reports - Newser
How to interpret RSI for MacroGenics Inc. stockInflation Watch & Risk Controlled Stock Pick Alerts - Newser
Can MacroGenics Inc. recover in the next quarterMarket Activity Recap & Community Verified Watchlist Alerts - Newser
Trend analysis for MacroGenics Inc. this week2025 Performance Recap & Verified Trade Idea Suggestions - Newser
Pattern recognition hints at MacroGenics Inc. upsideBear Alert & Expert Curated Trade Setups - Newser
Trend Report: Can MacroGenics Inc. stock double in the next yearTrade Entry Summary & High Return Trade Guides - khodrobank.com
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
How liquid is MacroGenics Inc. stockJuly 2025 Movers & AI Powered Trade Plan Recommendations - khodrobank.com
Institutional scanner results for MacroGenics Inc.2025 Fundamental Recap & Verified Short-Term Plans - Newser
What is MacroGenics Inc. s 5 year growth outlookQuarterly Market Summary & Expert Approved Momentum Trade Ideas - khodrobank.com
How to track smart money flows in MacroGenics Inc.Weekly Earnings Recap & Low Volatility Stock Suggestions - Newser
Smart tools for monitoring MacroGenics Inc.’s price action2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - Newser
Is MacroGenics Inc. stock heavily shortedJuly 2025 PreEarnings & Technical Entry and Exit Tips - khodrobank.com
Applying Elliott Wave Theory to MacroGenics Inc.2025 Technical Overview & Technical Pattern Alert System - Newser
Using fundamentals and technicals on MacroGenics Inc.2025 Top Gainers & Capital Efficient Trade Techniques - Newser
Is MacroGenics Inc. exposed to political riskFed Meeting & Verified Momentum Stock Watchlist - khodrobank.com
Will MacroGenics Inc. benefit from AI trends2025 Buyback Activity & Expert Curated Trade Setups - khodrobank.com
Technical Charts Suggest Momentum Shift in MacroGenics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Long term hold vs stop loss in MacroGenics Inc.2025 Pullback Review & AI Powered Market Trend Analysis - Newser
Can MacroGenics Inc. Rally Enough to Break Even getLinesFromResByArray error: size == 0 - 클래시안
Chart based exit strategy for MacroGenics Inc.Market Volume Report & Weekly Chart Analysis and Trade Guides - Newser
Published on: 2025-08-31 08:28:48 - Newser
How to build a custom watchlist for MacroGenics Inc.Earnings Recap Summary & Consistent Return Investment Signals - Newser
Analyzing net buyer seller activity in MacroGenics Inc.Trade Risk Report & Low Risk High Reward Ideas - Newser
Is MacroGenics Inc. stock reversal real or fakeJuly 2025 Outlook & Short-Term Trading Alerts - Newser
Published on: 2025-08-30 21:45:29 - Newser
Finanzdaten der Macrogenics Inc-Aktie (MGNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Macrogenics Inc-Aktie (MGNX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| HEIDEN WILLIAM K | Director |
Aug 20 '25 |
Buy |
1.49 |
49,500 |
73,755 |
111,000 |
| Koenig Scott | Director |
Aug 13 '25 |
Option Exercise |
0.00 |
52,829 |
0 |
830,244 |
| Bonvini Ezio | Sr VP, Research & CSO |
Feb 15 '25 |
Option Exercise |
0.00 |
16,665 |
0 |
124,414 |
| Karrels James | SVP, CFO and Secretary |
Feb 15 '25 |
Option Exercise |
0.00 |
14,998 |
0 |
192,591 |
| Koenig Scott | President and CEO |
Feb 15 '25 |
Option Exercise |
0.00 |
42,329 |
0 |
777,415 |
| Peters Jeffrey Stuart | Senior VP and General Counsel |
Feb 15 '25 |
Option Exercise |
0.00 |
13,332 |
0 |
18,858 |
| Risser Eric Blasius | Chief Operating Officer |
Feb 15 '25 |
Option Exercise |
0.00 |
16,665 |
0 |
62,422 |
| Smith Beth Ann | VP, Controller & Treasurer |
Feb 15 '25 |
Option Exercise |
0.00 |
1,095 |
0 |
9,955 |
| Smith Beth Ann | VP, Controller & Treasurer |
Feb 15 '25 |
Sale |
2.56 |
423 |
1,083 |
9,532 |
| Spitznagel Thomas | Sr VP, Technical Ops |
Feb 15 '25 |
Option Exercise |
0.00 |
13,332 |
0 |
26,922 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):